Very common (may affect more than 1 in 10 people): Nausea Vomiting Diarrhoea Constipation Abdominal (stomach) pain Headache Tiredness (fatigue) Low blood sugar (hypoglycaemia) in people with type 2 diabetes Common (may affect up to 1 in 10 people): Low blood sugar in people without type 2 diabetes Dizziness Altered taste (dysgeusia) and altered skin sensation (dysaesthesia) Indigestion (dyspepsia), heartburn / acid reflux (GORD), gastritis, burping, wind (flatulence) and bloating Increased heart rate Gallstones (cholelithiasis) Kidney stones (urolithiasis) Hair loss Increased blood levels of amylase, lipase and bilirubin Diabetic retinopathy in people with type 2 diabetes Hip fracture Uncommon to rare: Acute pancreatitis (inflammation of the pancreas) Low blood pressure (hypotension) and orthostatic hypotension Allergic reactions, including anaphylactic reaction and angioedema (swelling) Delayed gastric emptying and, rarely, intestinal obstruction Non-arteritic anterior ischaemic optic neuropathy (NAION), a rare eye condition that can cause sudden loss of vision Serious side effects
Nuestros programas incluyen: Evaluacin inicial en persona en una de nuestras clnicas de Tampa Planes de nutricin personalizados y educacin para adaptarse a su estilo de vida Recetas para perder peso (medicamentos enviados directamente a su domicilio) Recomendaciones de ejercicio basadas en su nivel de forma fsica actual Citas de seguimiento mensuales (virtuales o presenciales) para controlar el progreso Programa de prdida de peso virtual para pacientes fuera del rea de Tampa Informes de composicin corporal para controlar la grasa visceral, la prdida de masa muscular, etc
PlexusDx clinicians monitor this transition to ensure safe, sustainable progress
Before we give you the 4-1-1 on steps to apply makeup, we want to let you know there really is no set-in-stone correct order
If you need to change the day of the week on which you inject Mounjaro, make sure that at least three days have passed since your previous dose before administering it
10.1016/j.bmc.2004.11.028 47 FanjulC.BarrenetxeJ.IigoC.SakarY.DucrocR.BarberA.et al (2012)
